A Review of the Correlation Between Epidermal Growth Factor Receptor Mutation Status and (18)F-FDG Metabolic Activity in Non-Small Cell Lung Cancer

PET/CT with (18)F-2-fluoro-2-deoxyglucose ((18)F-FDG) has been proposed as a promising modality for diagnosing and monitoring treatment response and evaluating prognosis for patients with non-small cell lung cancer (NSCLC). The status of epidermal growth factor receptor (EGFR) mutation is a critical...

Descripción completa

Detalles Bibliográficos
Autores principales: Jiang, Maoqing, Zhang, Xiaohui, Chen, Yan, Chen, Ping, Guo, Xiuyu, Ma, Lijuan, Gao, Qiaoling, Mei, Weiqi, Zhang, Jingfeng, Zheng, Jianjun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9065410/
https://www.ncbi.nlm.nih.gov/pubmed/35515138
http://dx.doi.org/10.3389/fonc.2022.780186

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9065410/
https://www.ncbi.nlm.nih.gov/pubmed/35515138
http://dx.doi.org/10.3389/fonc.2022.780186

Ejemplares similares